Showing results (311-320 of 361) with videos related to

Sort By:
Pageof 37
The Journal of ECT|June 7, 2003
Decisional capacity of severely depressed patients requiring electroconvulsive therapyMaria I Lapid, Teresa A Rummans, Kristine L Poole, et al.
Familial Cancer|April 12, 2024
Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish womenMeghna S Trivedi, Haley Manley, Haeseung Yi, et al.
Social Psychiatry and Psychiatric Epidemiology|May 16, 2020
Exploring how a genetic attribution to disease relates to stigma experiences of Xhosa patients with schizophrenia in South AfricaOlivia P Matshabane, Megan M Campbell, Marlyn C Faure, et al.
Psychiatric Services (Washington, D.C.)|January 8, 2005
Use of leverage to improve adherence to psychiatric treatment in the communityJohn Monahan, Allison D Redlich, Jeffrey Swanson, et al.
Schizophrenia Bulletin|February 5, 2008
Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trialDilip V Jeste, Barton W Palmer, Shahrokh Golshan, et al.
Schizophrenia Research|December 19, 2015
Longitudinal informed consent competency in stable community patients with schizophrenia: A one-week training and one-year follow-up studyXueqin Wang, Xin Yu, Paul S Appelbaum, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 2, 2010
Deliberative assessment of surrogate consent in dementia researchScott Y H Kim, Rebecca A Uhlmann, Paul S Appelbaum, et al.
European Journal of Human Genetics : EJHG|May 16, 2022
Perceptions of causal attribution and attitudes to genetic testing among people with schizophrenia and their first-degree relativesMelissa B R Cullen, Bettina Meiser, Kristine Barlow-Stewart, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 30, 2014
The challenge of informed consent and return of results in translational genomics: empirical analysis and recommendationsGail E Henderson, Susan M Wolf, Kristine J Kuczynski, et al.
The American Journal of Managed Care|October 20, 2021
Reimbursement for genetic variant reinterpretation: five questions payers should askDavid L Veenstra, John W Rowe, José A Pagán, et al.
Pageof 37